stars 1 stars 2 stars 3

About Epoch Biosciences, Inc. (Pre-Merger) Epoch Biosciences, Inc. develops and sells proprietary products with commercial applications in the genomics and molecular diagnostics fields. Epoch's technology has numerous applications including the detection of inherited diseases, single nucleotide polymorphisms (SNPs) to identify individuals at risk for disease or adverse drug reactions, and gene expression measurement. The company's chemical reagents enhance the performance of genetic analysis procedures, and are compatible with the majority of DNA analysis systems currently employed or under development for research and diagnostic use. The company has an established presence in the research market through licenses to leading genomics companies, global distribution agreements and direct sales to end-users. Epoch also participates in the industrial/bioterrorism sectors and has entered the diagnostics market.

View Top Employees from Epoch Biosciences , Inc.

Epoch Biosciences , Inc. Questions

The Epoch Biosciences , Inc. annual revenue was $22 million in 2023.

Epoch Biosciences , Inc. is based in Bothell, Washington.

The NAICS codes for Epoch Biosciences , Inc. are [541713, 541, 5417, 54, 54171].

The SIC codes for Epoch Biosciences , Inc. are [873, 87].

How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users